The 2026 Insulin Patch: Needle-Free Delivery
A breakthrough for access in 2026 is the Vaxess semaglutide patch, which delivers GLP-1 medications and insulin without traditional needles.
Silk-Based Delivery: The patch uses silk-fibroin micro-needles that dissolve into the skin, releasing medication over hours or days.
Fridge-Free Storage: These patches are designed to be stable at room temperature, making them ideal for underserved areas or patients who travel frequently.
Simplified Compliance: Replacing a daily or weekly injection with a simple adhesive patch has significantly improved adherence in the pediatric and geriatric populations.
2 visualizações